Lithium Argentina to Release First Quarter 2024 Results on May 13, 2024
April 22, 2024 16:43 ET
|
Lithium Americas (Argentina) Corp.
Lithium Argentina will release its first quarter 2024 earnings results after market close on Monday, May 13, 2024.
First Bank Announces First Quarter 2024 Net Income of $12.5 Million
April 22, 2024 16:37 ET
|
First Bank
HAMILTON, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- First Bank (Nasdaq Global Market: FRBA) (the Bank) today announced results for the first quarter of 2024. Net income for the first quarter of 2024...
Hosting Coupon Codes Launches Expansive New Platform
April 22, 2024 16:36 ET
|
Hosting Coupon Codes
New York, NY, April 22, 2024 (GLOBE NEWSWIRE) -- Hosting Coupon Codes is pleased to announce the launch of its new website, https://hostingcoupon.codes/. Packed with web hosting coupons, daily...
EMGA secures US$ 15M financing for Banco Improsa in Costa Rica
April 22, 2024 16:35 ET
|
Emerging Markets Global Advisory
EMGA secures US$ 15M financing for Banco Improsa in Costa Rica
Theriva™ Biologics to Present Preclinical Data Supporting the Potential Synergy of VCN-01 and First-Line Pancreatic Cancer Chemotherapy Regimens at the American Society for Cell and Gene Therapy 27th Annual Meeting
April 22, 2024 16:35 ET
|
Theriva Biologics, Inc.
– Lead product candidate, VCN-01 in combination with liposomal irinotecan demonstrated enhanced anti-tumor effects in a human pancreatic mouse xenograft– – The observed synergy emphasizes VCN-01’s...
Ring Therapeutics Announces Presentations at the 27th Annual American Society of Gene and Cell Therapy
April 22, 2024 16:32 ET
|
Ring Therapeutics
Development of a new class of viral vectors – Anellovectors – with potential to deliver DNA payloads across broad tissue types in redosable manner Anellovectors demonstrate expanded payload capacity...
Excision BioTherapeutics to Present Positive Data from its HSV-1 Keratitis Program, EBT-104, at the ASGCT 2024 Annual Meeting
April 22, 2024 16:31 ET
|
Excision BioTherapeutics
Oral presentation to discuss CRISPR-associated gene editing inactivating herpes virusTwo poster presentations highlight the potential of EBT-104 for the treatment of HSV-1 Keratitis, demonstrating...
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
April 22, 2024 16:31 ET
|
ProQR Therapeutics N.V.
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA...
Editas Medicine to Present Pre-clinical Data Demonstrating Progression of in vivo Medicines Pipeline at the American Society of Gene and Cell Therapy Annual Meeting
April 22, 2024 16:31 ET
|
Editas Medicine, Inc.
CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage gene editing company, today announced that three abstracts have been accepted for...
iLearningEngines Reports Fourth Quarter and Full Year 2023 Results
April 22, 2024 16:30 ET
|
iLearningEngines Holdings, Inc.
Fourth quarter revenue grew 39% year-over-year to $116 million Posts record full year revenue of $421 million, up 36% year-over-year, and ARR growth accelerates to 43% year-over-year BETHESDA, Md.,...